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Abstract 
Long-Acting Reversible Contraceptive Methods,  
Same-Day Initiation and Early Removal 
Objective: The study was conducted to identify the early removal rate of Long-Acting 
Reversible Contraceptive (LARC) methods and factors associated with early removal. 
Study Design: A non-experimental descriptive design based upon retrospective chart 
review of electronic medical records (EMR) was used. There was a total of 96 subjects, 
ages 15-47 years who had a LARC method inserted within a 12-month time period and 
subsequent removal within 6-months of insertion date. Subjects were grouped 
according to same-day insertion versus non-same-day insertion.  
Results: Seventy percent of study subjects with early removal had their LARC method 
inserted under a same-day protocol. Most subjects were over 20 years of age, single, 
and of Hispanic ethnicity. The overall early removal rate for all LARC methods was 5%. 
Implant was the method most commonly removed followed by the levonorgesterel 
intrauterine system (IUS). Pain and bleeding were the most commonly cited reasons for 
removal. Oral contraceptive pills (OCPs) were the most commonly selected birth control 
method after removal of the LARC. 
Conclusion: A strategy to reduce barriers to contraceptive initiation is same-day 
insertion of the requested LARC method. However, research on LARC methods in 
conjunction with same-day initiation and continuation rates has not been done. This pilot 
study demonstrates a low early removal rate for LARC methods and offers support for a 
same-day initiation protocol. 
Sandra Loehner, 
May, 2014 
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INTRODUCTION 
Unintended pregnancy, defined as a mistimed, unplanned, or unwanted 
pregnancy (Centers for Disease Control and Prevention, CDC, 2013) is a growing public 
health concern. Forty-nine percent of pregnancies each year in the United States are 
classified as unwanted or mistimed (Trussell, 2007; CDC, 2013).  The cost associated 
with unintended pregnancy is significant with nationwide public expenditures reaching 
$11.1 billion in 2006 (Sonfeld, Kost, Benson, Gold & Finer, 2011). Moreover, in 2006, 
California was among the states spending the most on publicly-funded births, at a rate 
of $1.3 billion (Sonfeld et al., 2011).  
Adolescent unintended pregnancy is of particular concern. Greater than 80% of 
adolescent pregnancies are unplanned, accounting for one-fifth of all unintended 
pregnancies in the United States (American Congress of Obstetricians &Gynecologists, 
ACOG, 2012). Specific to California, the teen pregnancy rate for ages 15-19 years is 
38.4/1000 women, lower than the national average of 41.5/1000 women respectively 
(Mathews, Sutton, Hamilton, & Ventura, 2010). Government expenditures associated 
with unintended pregnancies in the Central Valley of California are unknown. However, 
State teen pregnancy rates, most of which are also assumed to be unplanned, are 
highest in San Joaquin Valley counties (California Department of Education, 2012).  
Along with adolescents, economically disadvantaged women demonstrate some 
of the greatest unintended pregnancy rates (CDC, 2013; Finer & Zolna, 2011; 
Guttmacher Institute, 2013).  Healthy People, 2020 has set an agenda of reducing 
unintended pregnancy due to the national health implications inherent to unplanned 
births (“Healthy People, 2020”, 2013). Likewise, the Affordable Care Act (Health and 
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Human Services, 2013) provides reproductive and family planning services coverage in 
the hope to reduce unwanted pregnancies. 
Despite national attention on the unintended pregnancy rate, research on 
effective strategies to achieve this goal is minimal (Taylor & James, 2011). 
Contraceptive options currently available in the United States are varied and include 
barrier methods (male/female condoms, diaphragm), combined hormonal contraception 
(oral contraceptive pills (OCPs), contraceptive patch, vaginal ring), and progestin 
methods (progestin-only pills, depo-medroxyprogesterone acetate injection (DMPA)).  
Long-acting reversible contraceptive (LARC) devices which include the intrauterine 
copper contraceptive (IUD), the levonorgesterel-releasing intrauterine system (IUS) and 
the etonogestrel contraceptive implant are also among the currently available 
contraceptive options. These methods are classified as long-acting methods due to the 
long-term contraceptive efficacy of each: the IUD is effective for 10 years, the IUS is 
effective for 5 years, and the contraceptive implant is effective for 3 years. However, 
LARC methods have some of the lowest rates of use among women of reproductive 
age. Only 8.5% of all women using contraception in 2009 used a LARC method, with 
4.5% of women between 15-19 years of age using a LARC device (ACOG, 2012). . 
Short-acting contraceptive methods such as OCPs, contraceptive patch, vaginal 
ring, and DMPA are more frequently prescribed, but have greater likelihood of lower 
continuations rates and higher pregnancy rates than LARC methods. Unintended 
pregnancy rates were two times greater in women younger than 21 years using short-
acting contraceptives as compared to older women using short-acting contraceptive 
methods (ACOG, 2012). It is reported that nationally, 1 million pregnancies each year 
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arise from discontinuation or incorrect use of OCPs (Garbers, Meserve, Kottke, Hatcher 
& Chiasson, 2012). Most women in the United States use contraceptives with 
adherence requirements. Incorrect or inconsistent use of short-acting contraceptives 
results in pregnancy rates higher than rates in LARC method users (Peipert et al., 
2011).  
Cost effectiveness of any contraception, in part, is contingent upon compliance 
with and continuation of the method. Early discontinuation of LARC methods especially, 
has a negative impact on expense since higher cost at initiation is not offset by 
continued use of the method (Mavrenozouli, 2009). 
Contraception initiation using the Quick Start method has been researched in 
terms of contraceptive continuation rates and barriers to starting contraceptives. Quick 
Start, defined as the immediate, in-clinic start of hormonal methods, has demonstrated 
at least equal if not greater short-term continuation rates for the chosen birth control 
method over traditional start (Sunday after next expected menses) option (Lopez, 
Newmann, Grimes, Nanda & Schulz, 2012; Nelson & Katz,, 2007; Westhoff, Heartwell, 
et al., 2007). Quick-Start initiation is also a strategy to reduce barriers to starting 
contraception, and was first used for OCPs (Westhoff, Kerns, et al., 2002). Quick start 
has now been adapted to include other hormonal methods such as contraceptive patch, 
(Murthy, Creinin, Harwood, & Schreiber, 2005; Lopez et al, 2012); DMPA injection 
(Nelson & Katz, 2007, Lopez et al. 2012); and the vaginal ring (Lopez et al., 2012). 
To date, Quick-Start and LARC methods have not been reported in the literature. 
However, a similar concept, same-day initiation, is practiced at the study sites. The U.S. 
Selected Practice Recommendations for Contraceptive Use: 2013 (CDC, 2013) 
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supports LARC insertion any day of the menstrual cycle as long as it is reasonably 
certain the women is not pregnant. Thus far, no research has examined the relationship 
between LARC methods, same day initiation and continuation rates of the LARC 
method. Therefore, the purpose of this study is to explore same day insertion of LARC 
methods and subsequent removal rates within 6 months of original insertion date. 
This research study aims to answer the following questions: 
1. What is the rate of early LARC removal? 
2. Is there an association between mean number of days LARC used and 
same day insertion? 
3. Is there an association between demographic factors (age, body mass 
index (BMI)) and early removal rates? 
4. What are the most common reasons for early LARC removal? 
5. What is the most common birth control method chosen after LARC 
removal? 
Theoretical Framework 
The conceptual framework for this study is based upon the theory of planned 
behavior (TPB) (Ajzen, 1991, Ajzen, 1992). The TPB is a model that addresses 
behavioral action and attitudes involved with decision making while providing a 
framework for understanding patient motivations in decision making. There are three 
main assumptions of TPB: perceived behavioral control, behavioral beliefs, and 
subjective norm. Perceived behavioral control is the perception of ability to perform an 
action. Behavioral beliefs form the attitude toward a behavior. Subjective norm is the 
perception of how others will perceive a given action. Intention to act results from the 
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interplay of TPB’s main assumptions and is the immediate antecedent to the actual 
behavior.  
The assumptions found in the TPB model are congruent with the current project. 
The patient who chooses/acts to have an early removal of a LARC method (not related 
to physiologic complaints) has a strong sense of control or ability to follow through with 
making and getting to her appointment for removal, does not feel a strong sense of 
negative consequence from her family or significant others in removing the method, and 
either does not have a strong attitude or commitment to effective birth control or 
minimizes the threat of pregnancy when not using a LARC method. The relationship of 
all these factors results in the behavior of asking for early removal of her birth control 
method.  
Perhaps better education on pregnancy risk or discussion on the efficacy of the 
LARC method will be necessary to strengthen the patient’s attitude toward not removing 
the method. Improved understanding of LARC efficacy, in turn, may override subjective 
norms and behavioral control attitudes so intention to remove the method is dampened 
and the behavior does not occur. The results of this project, in conjunction with TPB, 
may offer avenues for further research on patient education options to reduce frequency 
of early LARC removal. 
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REVIEW OF LITERATURE 
The current study aims to examine early LARC removal rate among women 
attending two women’s health clinics. Additionally, this study aims to identify any 
demographic characteristics associated with early LARC removal among women 
undergoing same day insertion of a LARC device. Other areas aim to explore reasons 
for early LARC removal and choice of birth control after LARC removal.   
To date, little research has examined early LARC device removal in conjunction 
with same day insertion. There is some research that has examined immediate post-
partum or post-abortal insertion; however the focus of this project is on early LARC 
removal in women having same day insertion unrelated to delivery or abortion.  
The following review of the literature will focus on research discussing 
continuation and satisfaction rates of contraception methods which include LARC in the 
design, as well as continuation studies specific to LARC methods. Research exploring 
characteristics of users of LARC methods will also be presented. 
Continuation/Satisfaction Rates of Contraceptive Methods 
Peipert et al. (2011) compared 12-month satisfaction and continuation rates 
among women using LARC methods (copper IUD, levonorgestrel IUS, contraceptive 
implant) (n= 2,846; 68%) to women using non-long-acting methods (OCPs, 
contraceptive patch, vaginal ring, DMPA) (n=1,321; 32%). Demographics for all study 
participants included an age range between 14-45 years, with a mean age of 
approximately 25 years (sd=5.7); 47%  were African American; 34% had a high school 
diploma or less; 48% were nulliparous; 66% had a history of unintended pregnancy; and 
40% had a history of abortion. Overall, LARC method users were older (p=.001), had a 
higher parity (p=.001), unintended pregnancy history (p=.001), and were less educated 
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(p=.004) than subjects who chose non-long-acting methods. Continuation rates for 
participants using LARC methods were high ranging from 83-88% dependent upon 
LARC method used compared to 45% continuation rate for those using OCPs, 
contraceptive patch, vaginal ring or DMPA.  
 Moreau, Cleland, and Trussell (2007) explored contraceptive discontinuation in 
conjunction with method dissatisfaction in a retrospective survey. Women aged 15-44 
years (N=6,724) living in the United States, completed an 85-minute questionnaire 
assessing contraceptive methods, dissatisfaction, and reasons for discontinuation. 
Forty-six percent (n=2448) reported discontinuing at least one type of contraception due 
to method dissatisfaction. Primary reasons included side effects and menstrual 
changes. Thirty-six percent (n=145) of women who had used the IUD reported stopping 
this method due to dissatisfaction, however specific reason(s) were not presented.  
Twenty-nine percent (n=1,637) of subjects stopped OCPs due to method dissatisfaction 
which was one of the lowest for all medical methods of contraception. However, the 
lowest rates of discontinuation due to dissatisfaction were condoms (11.9%), 
withdrawal, (12.6%) and fertility awareness (14.6%).  
Continuation/Satisfaction Rates of LARC Methods 
Understanding satisfaction rates, reasons for LARC early removal and side 
effects of LARC devices has been the impetus of several research studies. Jeffreys and 
Clark (2012) prospectively followed 131 women from contraceptive implant insertion 
through point of removal. Twenty-five percent (n=33) kept the implant for the full 
approved duration (36 months). At 1 year post-insertion, 90% (n=118) had implants in 
place with a 53% (n=69) retention rate at year 2. Irregular bleeding was the primary 
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reason for early implant removal. A two-stage procedure was used for device insertion 
with intensive counseling regarding side effects and ways to manage the most common 
side effect of irregular bleeding. The second step was the actual appointment for the 
implant insertion during the first 5 days of the menstrual cycle. Although this study 
demonstrated high continuation rates for the contraceptive implant, a time delay barrier 
to insertion was created by a 2-stage insertion process. 
 Lakha and Glasier (2006) examined medical record data to identify continuation 
rates for the contraceptive implant among women in the United Kingdom. A combination 
of medical record data and mailed questionnaire were used for data analysis. Data was 
available for 277 women. An 89% (N=246) continuation rate was noted at 6 months, 
75% (n= 207) at 1 year, 59% (n=163) at 2 years, and 47% (n=130) at 2 years and 9 
months. The primary reasons for removal within the first year included unpredictable 
bleeding pattern, weight gain, and mood changes.  
Contraceptive implant continuation rate was also examined in a retrospective 
chart review of 767 Australian women (Harvey, Seib, & Lucke, 2009) with results similar 
to Lakha and Glasier (2006). Continuation rates were 94% (n=563) at 6 months, 74% 
(n=440) at 1 year and 50% (n=364) at 2 years. Bleeding pattern disruption was cited as 
the primary reason for discontinuation, with over 50% of women offering this as the 
reason for premature removal.  
Alton et al. (2012) focused on IUD/IUS continuation rates and risk factors for 
IUD/IUS removal in a sample including both adolescents and young women (N= 233). A 
retrospective, descriptive study design was used to evaluate outcomes after IUD/IUS 
insertion in patients 21 years of age or younger, spanning an 8-year study time frame. 
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Median age at insertion was 16 years (range 11-21 years). Thirty percent of subjects 
(n=71) were nulliparous with 69.9% of subjects (n=164) having a prior pregnancy. 
Findings suggested participants < 18 years of age were 3.5 times more likely to remove 
or expel their device compared to participants 18-21 years of age (p=<0.001). 
Nulliparous patients were 2.9 times more likely to remove or expel their device 
compared to multiparous women (p= 0.001). a 50% continuation rate was noted among 
those <18 years of age (n=34) compared with a 71.5% continuation rate for those 
between 18-21 years of age (n=117). The highest levels of removal occurred in the first 
2 years of use regardless of subject age. 
 Using a 17-item telephone survey, Dickerson et al. (2013) identified level of 
satisfaction, side effects, and early removal data for LARC method users (contraceptive 
implant, IUD, IUS). The sample included 129 women 18 years of age or older for a total 
of 132 responses (3 women were surveyed twice due to both IUD and implant use 
during the study period). Black women accounted for 66.7% (n=88) of subjects; 32.6% 
(n=43) were white. LARC satisfaction was categorized on a Likert scale (very satisfied, 
rather satisfied, rather dissatisfied, and very dissatisfied). Likert responses were 
grouped into either satisfied or dissatisfied categories. Early removal rates were defined 
as follows; contraceptive implant before 34 months (36 month maximum), and IUD 58 
months for both the 60 month levonorgesterel IUS and120 month copper IUD. Fifty-
eight percent (n=77) of the sample chose IUDs and 41.7% (n=55) chose the 
contraceptive implant. Results indicated 72.7% (n=96) were satisfied with their LARC 
method with 24.2% (n= 32) requesting early removal. Pain and bleeding irregularity 
were the most common complaints for IUD. However, multivariate analysis did not 
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demonstrate any correlation to pain, or bleeding and early removal. Depression, though, 
was a statistically significant reason for removal (p< .01). Although there is no 
consensus regarding a definition for early LARC removal, Dickerson et al. (2013) are 
the only researchers who have categorized early removal as removal within months of 
LARC device expiration making comparison to other studies challenging given such a 
different time-frame definition. 
In a qualitative study Hoggart and Newton (2013) explored reasons for early 
contraceptive implant removal. Twenty participants, aged 16-22 years were interviewed 
individually using a semi-structured interview guide. Most of the participants reported 
having their implant removed within a year of insertion. A main theme included 
reassertion of bodily control influencing contraceptive implant removal and choice of 
contraceptive method after removal. Secondary side effects included weight gain, mood 
changes, acne, and pain at insertion site. 
Demographic Characteristics Associated with LARC Methods 
Xu et al. (2011) examined demographic characteristics of study participants 
using the IUD (levonorgesterel IUS, copper IUD), reasons for choosing the IUD over 
other contraceptive methods, and satisfaction with the IUD. The National Survey of 
Family Growth data (2006, 2008) and a Guttmacher Institute telephone survey (2004) 
were analyzed. The study size was 3,005 women, aged 18-44 years. Type of 
contraceptive method being used by the subject at the time of the interview was 
determined with results indicating 5.2% (n=156) of participants were IUD users, while 
43.4% (N= 1,304) used either OCPs or the contraceptive patch. IUD users had higher 
family incomes (43.4%), reported some college education (61.7%), were of Hispanic 
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descent (24.6%), and had private health insurance (59%). IUD users reported the 
highest proportion of complete satisfaction with this method (82.3%) in comparison to 
74.7% complete satisfaction rating by users of other hormonal methods. 
Grunloh, Casner, Secura, Peipert and Madden (2013) used phone interview at 3 
and 6 months post LARC insertion along with review of clinic LARC removal logs to 
examine demographic characteristics associated with women removing their LARC 
method within the first 6 months of use. Sample size consisted of 5, 928 women 14 
years of age and older. Logistic regression was used in data analysis. Sixty-one percent 
of subjects (n= 3,610) had the levonorgestrel IUS, 23% (n=1, 366) the implant, and 16% 
(n= 952) the copper IUD. Characteristics between 2 subject groups: LARC users > 6 
months and LARC user < 6 months were compared. Seven percent (n=433) of total 
subjects had early LARC removal. There was similarity in discontinuation rates for all 3 
LARC methods: 7.3% for IUS, 8% for copper IUD, and 6.9% for implant users (sd=.60). 
Researchers compared demographic characteristics for women continuing their LARC 
method to subjects who removed their LARC. There were no significant differences in 
age, education, insurance coverage status, parity, prior unintended pregnancy history, 
and body mass index (BMI) between the 2 groups. Subjects who were single (adjusted 
OR 1.26, 95% CI 1.01-1.59), divorced, separated or widowed (adjusted OR 1.62, 95% 
CI 1.11-2.37) were more likely to discontinue the LARC method by 6 months. Young 
age (14-19 years) showed no association with early discontinuation (odds ratio = 1.16; 
CI = .87-1.54). Irregular bleeding was a reason for removal for all 3 LARC methods: 
IUS, 9.5% (N= 14), copper IUD, 19.2% (N= 10) and implant 53.2% (N= 50). Pain or 
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cramping complaint was only found in the copper IUD (35%, n=18) and IUS (28%, 
n=41) subjects. 
Research on reasons for LARC removal, continuation rates of LARC methods 
and demographic characteristics of LARC users all add to the body of knowledge 
available to clinicians providing this form of contraception. The current research study 
will build upon what has previously been examined, and offer LARC data on early 
removal rates and same day initiation.   
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METHODOLOGY 
 
The following sections discuss the study’s methodology. The research design, 
sample selection, setting, data collection, and data analysis will be addressed. 
Research Design 
A non-experimental, correlational, descriptive design based upon retrospective 
chart review of electronic health records (EHR) was conducted after approval by the 
institutional review board at the University.  A retrospective chart review offered 
important data to assess percentage of early removal rates, percentage of patients 
having same-day insertion of a LARC method, as well as selected demographic 
characteristics of the sample subjects.  
There is no consensus on a definition for early LARC removal in the literature. 
Any LARC method removed prior to the life of the device constitutes early removal. 
Studies in the literature on early LARC removal range from 6 months to greater than 2 
years (Alton et al., 2012; Dickerson et al., 2013; Grunloh et al, 2013; Harvey, Seib & 
Lucke, 2009; Lakha & Glasier, 2006). This study defined early LARC removal as device 
removal within 6 months of original insertion date which falls within the time frame of 
other studies. 
Sample 
Participant Electronic Health Records (EHR) were included in this study if they 
had a LARC method of birth control inserted at one of the two identified community 
clinics and were between 12-50 years of age.  Exclusion criteria were immediate post-
abortal/postpartum LARC insertion or removal of expired LARC device. A de-identified 
study data set was assembled of all LARC insertions between June 2012 through June 
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2013 using specific billing codes (see Table 1). This list was then used to identify the 
total LARC removals within 6 months of insertion. The total number of early removals 
that were same-day insertions were captured by individual chart review. 
Study Setting 
 The study setting included two community clinics that are part of a non-profit 
women’s health organization. Both of the clinics are located in urban areas with the first 
clinic located in Santa Clara County, California, and the second located in Fresno 
County, California.  Both clinics are staffed with a comparable clinician mix, see a 
similar number of patients, and offer a similar range of health care services including; 
primary care, family planning, women’s health, male health services, and prenatal care.  
Data Collection 
The Information Technology (IT) department of the organization compiled chart 
numbers for the researcher using the following diagnostic codes (Table 1) to achieve 
the total number of LARC insertions and early removals during the designated time 
frame. 
Table 1. LARC Insertion and Removal Codes 
 
Insertion Code Explanation 
S 30.1 Implant initial evaluation 
S 30.2 Implant Follow-up 
S 40.1 IUC initial evaluation 
S 40.2 IUC follow-up 
V 25.5 Implant insertion 
V25.11 IUC insertion 
V25.22 IUC insertion 
 
Removal Code 
 
S 30.2 Implant follow-up 
V25.43 Implant check or removal 
S 40.2 IUC follow-up 
15 
 
 
 
A total of 96 subjects met the study parameters and were used in data analysis. 
There was a total of 1, 918 total LARC insertions from both sites compiled from billing 
codes. Of those, 257charts were selected for a removal diagnosis. Some records were 
omitted because LARC insertion did occur post-abortion when the record was reviewed 
on-line. One subject was eliminated due to pregnancy as reason for removal; 13 other 
charts were captured under the billing codes but did not fall under study criteria. See 
Figure 1 for further information on accounting of study subjects.  
Figure 1: Subject Selection 
 
A de-identified dataset was compiled from the EHR of subjects meeting study 
criteria. Data extracted included a) demographic data; b) reason for removal; c) whether 
the participant underwent same-day LARC insertion; and d) method of birth control 
chosen after LARC removal. Standardization of reasons for LARC removal is present in 
V25.12 IUC removal 
1,918 total insertions
257 charts from 
billing codes
88 LARC used longer 
than 6 months
18 removals/re-
insertions on same day
96 charts used for analysis
13 other
42 immediate post-
abortion insertion
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EHR (see Appendix A). Viewing selected radio buttons determined which reason(s) for 
removal was extracted. 
 Demographic characteristics compiled included age, race/ethnicity, marital 
status, pregnancy history, body mass index, and monthly income. Same-day LARC 
initiation was determined by assessing whether the study participant received her LARC 
method on the day first requested without evidence of prior use of LARC method or 
previous counseling on LARC method. If prior use, prior counseling, or free text clinician 
comments indicated prior information on LARC method discussed within a clinic setting, 
the subjects was classified as a non-same day initiation. Contraceptive method chosen 
after removal was obtained either through indication in the EHR on birth control method 
at end of visit indicator, type of contraceptive supply provided the day of removal, or 
through the billing code. 
Data Analysis 
Descriptive data was analyzed using means, frequencies, and measures of central 
tendency. Associations were assessed using inferential statistics appropriate to data 
collected (independent samples t-test and ANOVA). 
Ethical Considerations 
 University nursing department IRB approval was granted on the basis of a 
retrospective chart review, in conjunction with de-identification of participant data. All 
data were kept secure in a locked file cabinet at the researcher’s place of employment. 
Given the study design, individual informed consent was waived by the IRB. Consent for 
medical services obtained through the clinic sites was obtained on the date of service. 
17 
 
Organizational approval was obtained via the organization’s Chief Medical Officer after 
review of the study proposal. 
Bias 
Bias for this study was nominal. A retrospective chart review of EHR minimizes 
the researcher’s ability to distort or manipulate findings in any systematic way. Selection 
bias was also reduced by including all subjects who met the early removal criteria of the 
study (excluding post-abortal/ post-partum and device expiration insertion as previously 
addressed) and not selectively choosing subjects for analysis. Additionally, the early 
removal subject list was extracted from billing codes by someone other than the 
researcher, to further reduce the risk for subject selection bias (Melynk & Fineout-
Overholt, 2011). 
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RESULTS 
 
Demographics 
 Of the 96 eligible participants, 75% (n=67) were single, 48% (n=45) self-identified 
as Hispanic, and 48% (n=43) reported no current monthly income (range $0-$2,688). 
Mean age of subjects was 24 (sd=6.4) years, with a range of 15 to 47 years. Please see 
Table 2 for more complete demographic data. 
Table 2. 
Demographic Data 
Participant 
Characteristic 
     N* (%)  
    Mean (in years) 
(SD) 
   SD 
Age  24                 (6.4) 
Gravidity  
     0      36 (37.5)  
     1      24 (25)  
     ≥2      36 (37.5)  
Parity 
     0      49 (51%)  
     1      28 (29%)  
     ≥2      19 (20%)  
Marital Status* 
   Single      67 (75%)  
   Married      10 (11%)  
   Other      12 (13%)  
Race 
   Caucasian      24 (25%)  
   Hispanic      45 (48%)  
   African 
American 
      4 (4%)  
   Asian       3 (3%)  
  Other      20 (21%)  
Income* 
 
      No monthly 
income 
 
 
 $0/month      43 (48%)  
  $100-
$999/month 
     31 (35%)  
  $>1,000/month      15 (17%)  
 
*Missing data in respective category 
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LARC Early Removal Rate 
 
 During the study time frame, 1,918 total LARCs were inserted with the IUS most 
frequently inserted at a rate of 45% (n=880), the implant was the next most requested 
LARC device at 35% (n=674), with the IUD third, at 20% (n= 364). The first study 
question was to address the rate of early LARC removal. The early LARC removal rate 
was 5%. Same day insertion occurred in 70% of study subjects. See Table 3 for the 
frequency of early LARC removal by type. 
Table 3. 
Frequency and Percent of Early LARC Removal by Type (N = 96) 
LARC Type n % 
Implant 43 44.2 
IUS 33 34.7 
IUD 20 21.1 
 
Days LARC Used and Same Day Insertion 
 
 The second study question was to determine if there was a correlation between 
mean number of days LARC was used and same day insertion. An independent 
samples t-test was conducted for this analysis. An independent groups t-test indicated 
no significant difference in the mean number of days LARC was used between same-
day LARC insertion (Table 4). 
Table 4. 
Mean Number of Days Used and Standard Deviation for LARC Insertion (N = 96) 
 
 
 
 
LARC Insertion n M SD 
Same-day insertion 67 88.51 54.473 
Non-same-day 29 95.21 55.696 
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Demographics and Early LARC Removal 
The third study question was to determine if age or BMI demonstrated an 
association with early LARC removal. A Pearson correlation was conducted to analyze 
age and early LARC removal. Correlation results indicated there was no significant 
relationship between age and the number of days LARC was used; r (96) = -.174, p = 
.090, r2 = .030. BMI also demonstrated no significant relationship with number of days 
LARC was used;  r (96) = -.045, p = .662, r2 = .002. 
Reasons for Early LARC Removal 
The fourth study question was common reasons for early LARC removal. Pain 
(30%, n=29) and bleeding (28%, n= 27) were the most often cited reasons in this study. 
The category of symptoms/side effects accounted for 25% (n=24) (see Table 5) of 
subjects having early removal. Only if clinicians free texted symptom or side effect detail 
could specific information be extracted from EHR. Reasons that were found included 
headache, depression, shortness of breath and partner feels the string. However, these 
free text complaints accounted for only 1 or 2 subjects per complaint and therefore did 
not warrant discrete analysis. 
Table 5. 
Frequency and Percent of Early LARC Removal by Reason (N = 95*) 
*Missing data in 1 chart                                        BCM= birth control method 
Reason for Removal n % 
Pain 29 30.5 
Bleeding 27 28.4 
Symptoms/Side Effects 24 25.3 
Other 07 07.4 
 
 
Desires pregnancy 04 04.2 
Requests other BCM 03 03.2 
No longer needs BCM 01 01.1 
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Additionally, a one-way analysis of variance was conducted to determine the 
mean difference on the number of days LARC was used and reasons for removal 
(symptoms / side effects, pain, or bleeding). ANOVA results showed the mean number 
of days LARC was used and reason for removal was statistically significant, F(2, 77) = 
3.131, p = .049.  Post-hoc LSD test revealed that women who report pain as a reason 
for removal used LARC significantly less number of days (M = 71.31, SD = 55.711) than 
women who report bleeding as a reason for removal (M = 103.67, SD = 48.450). 
Women who report symptoms or side effects did not significantly differ in the number of 
days LARC was used (M = 98.50, SD = 50.988) between the other two groups.  
Contraception after Early Removal 
 The final study question examined the most common birth control method 
chosen after early removal. Forty percent (n=38) of participants chose OCPs as their 
post-removal contraceptive. Thirty-eight percent of women chose non-hormonal 
methods of birth control. Condoms combined with using no method accounted for the 
second largest number of participants. Only 5% of women chose to continue with a 
different LARC method after removal of the first device (see Table 6). 
Table 6. 
Frequency and Percent of Birth Control Method after Removal (N = 95*) 
Birth Control Method n % 
Oral Contraceptive Pills 38 40.0 
Condoms 25 26.3 
Other/Nothing 11 11.6 
Contraceptive Ring 09 09.5 
DMPA 04 04.1 
Contraceptive Patch 02 02.1 
IUS 02 02.1 
IUD 02 02.1 
Implant 01 01.1 
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Diaphragm 01 01.1 
 
*Missing data in 1 chart 
DMPA = depo-medroxyprogesterone acetate injection; IUS = levonorgesterel-releasing system 
IUD = intrauterine copper contraceptive 
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DISCUSSION 
 
 The purpose of this pilot study was to explore same day insertion of LARC 
methods and subsequent removal rates within 6 months of original insertion date. 
Results will be discussed in relation to previous research and propose areas for future 
research.Strengths and weaknesses of the study will also be evaluated. 
 The study found low rates of LARC early removal, (5%), which were lower than 
rates reported in other research. Grunloh, Casner, Secura, Peipert and Madden (2013) 
reported an early removal rate at 6 months of use of 7.3% for the IUS, 8.0% for the IUD, 
and 6.9% for the implant. Jeffreys & Clark (2012) reported a 12-month removal rate of 
10%. Peipert et al. (2011) demonstrated a 17% early removal rate in implant users at 12 
months, while IUD/IUS users had a 12-16% early removal rate depending upon type of 
device. Dickerson et al. (2013) reported a 24% early removal rate at 34 months of use. 
This study in conjunction with other research on LARC continuation rates suggests high 
rates of retention shortly after insertion with increasing rates of early removal over time. 
Early removal of LARC methods as a function of same day insertion was specific to this 
study and was not previously addressed in other research. Although 70% of early 
removal subjects were classified as same day insertions, an independent group t-test 
indicated no significant difference in mean number of days LARC used and same-day 
LARC insertion.  
 Demographic characteristics of age and BMI did not demonstrate any significant 
correlation to early LARC removal. However, an unexpected finding was the minimal 
number of teen subjects (21%, n=20) in the study population. Grunloh, Casner, Secura, 
Peipert and Madden (2013) reported only 16% (n=71) of their subjects were 14-19 
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years of age in the 6 month LARC early removal group. Participant mean age was 
similar for this study (24 years) as Peipert et al. (2011) which demonstrated a mean age 
of 25 years. Mestad et al. (2011) specifically analyzed  LARC use in adolescents 14-17 
years and women 18-20 years and found a 70% (n=3557) rate of LARC use, however, 
continuation rates were not analyzed. Further research on rates of LARC use in a teen 
population, LARC continuation rates in teens, as well as strategies to increase teen 
utilization of LARC methods may still be needed.  
  Pain complaint was associated with the shortest time of LARC use, 
approximately 2 ½ months (M=71.31 days). Bleeding, the second most common reason 
for removal, demonstrated a one month longer LARC use time (M=103.67 days). 
Hoggart and Newton (2013) found bleeding irregularities the most common reason for 
implant removal. Grunloh, Casner, Secura, Peipert and Madden (2013) also found pain 
or cramping the  most common complaint for early removal of IUS/IUD at 62% 
combined (n= 200), while 53% (n=50) of implant users reported bleeding irregularities 
as reason for early removal. Dickerson et al. (2013) reported pain complaint most 
commonly associated with the Levonorgestrel IUD, and bleeding the most common 
complaint for the implant, however, there was no association to complaint and early 
removal rates. Analysis by type of LARC and reason for removal was not performed 
with this study, but could be an area for future research. 
Type of birth control method chosen after LARC removal was the final question 
addressed in this study. Combined hormonal contraception was the most common 
category selected. Condoms were the second choice, followed by no method as the 
third choice. Selecting a different LARC device was one of the least preferred options 
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for study participants. The decision to choose a less reliable form of contraception after 
LARC removal has consequences for the patient who could risk an unplanned 
pregnancy. Hoggart and Newton (2013) found less reliable contraception choices after 
implant removal in their qualitative study (80%, n=16) as well. However, other research 
already presented did not analyze method of birth control after LARC removal 
(Dickerson et al, 2013; Grunloh, Casner, Secura, Peipert, Madden, 2013; Mestad et al, 
2011; Peipert et al., 2011). Further research on birth control selection post-removal is 
still needed.  
In the current study, participant decision to use a method post-removal that 
regulates bleeding patterns such as OCPs may reflect a desire to end bleeding 
irregularities and still maintain a degree of contraceptive effectiveness. Choosing 
condoms or no method may demonstrate a desire to move away from artificial hormone 
regulation in general, similar to the motivations found by Hoggart and Newton (2013).  
In their study, the action of removing the implant was a means for the participant to re-
assert bodily control that had been lost. Emphasizing bodily control over reproductive 
control impacted contraceptive choice after implant removal. Participants opted for less 
reliable contraception in the form of pills, condoms, or no method of birth control to 
reduce perceived hormonal side effects or eliminate bleeding irregularities. Future 
research could better explore bodily control or behavioral action within the context of the 
theory of planned behavior via a prospective study design. Likewise, strategies to 
improve patient counseling on common side effects and emphasis on efficacy of LARC 
methods may be an area for future research to reduce the frequency of pill or condom 
choice post-LARC removal. 
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All studies have strengths and limitations. A strength of this study is pilot 
research done on an emerging issue in contraception. Given the impetus to reduce 
barriers to contraceptive availability and expanded use of LARC methods, studies on 
consequences of same day initiation and LARC methods is necessary. Results from the 
study will contribute to the literature on LARC devices especially in the area of early 
removal rates and provision of LARC within the context of same-day insertion. A second 
strength is the study setting. Utilizing participants who have received care within a 
nationally recognized women’s health organization which standardizes patient 
education and has clinicians comfortable with providing LARC methods reduces 
potential bias compared to a study performed in a private practice setting. 
A limitation of this study is the defined participant group characteristics which 
limit generalizability to women outside of the study setting. Retrospective chart review is 
another limitation. Accuracy of data collected from electronic health records is 
contingent upon the accuracy of the clinician who provided the service and not the 
researcher looking for key data points. Omissions in documentation on whom previously 
received LARC counseling or lack of charting on reasons for removal could have altered 
the study’s findings. The concept of same-day insertion is also an area that risks study 
bias. Same-day insertion suggests the patient has had no previous counseling on a 
method and makes a decision at point of service to choose a LARC method. However, 
this is not always the case. Patients have the ability to do their own research on a 
method, talk with family and friends using that method and reflect on how that method 
would work for them. In fact, a patient could come to the clinic appointment for LARC 
insertion with a better understanding of the LARC method they desire than a patient 
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with previous counseling classified as a non-same day insertion. Finally, the lack of 
comparison group in this study design weakens the study findings. If the early removal 
subjects were compared to subjects who had retained their LARC on factors such as 
demographics, or pain and bleeding complaints, validity of findings would have been 
strengthened  
Unintended pregnancy in the United States continues to be a public health 
concern. Further research on LARC methods may be one strategy to improve patient 
education and counseling on these highly effective devices. Increased provider 
confidence and acceptance of LARC methods for most reproductive-aged women, 
including teens, would also be a beneficial outcome of continued studies. 
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APPENDIX A 
Reasons for Removal: Implant 
 
 
 
Reasons for Removal: IUD/IUS 
 
 
 
 
 
 
 
